10.3760/cma.j.issn.1003-9279.2019.03.017
HBeAg阴性初治慢乙肝患者恩替卡韦3年抗病毒治疗APRI评分动态变化研究
肝炎、乙型、慢性、肝纤维化、恩替卡韦、APRI评分
33
首都临床特色应用研究专项Z151100004015122;北京市医院管理局临床医学发展专项XMLX 201706;北京市医院管理中心消化内科学科协同发展中心XXZ0302;国家科技重大专项2017ZX10201201-001-006;北京市医管中心培育计划PX2018060;北京市医管中心青苗计划QML20181803;北京地坛医院育苗计划DTYM201609;Beijing Municipal Science & Technology CommissionZ151100004015122;Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding SupportXMLX201706;The Digestive Medical Coordinated Development Center of Beijing Hospitals AuthorityXXZ0302;National Science and Technology Major Project of China2017ZX10201201-001-006;Beijing Hospitals Authority Incubating ProgramPX2018060;Beijing Hospitals Authority Youth ProgrammeQML20181803;Seedling Cultivation Programme of Beijing Ditan HospitalDTYM201609
2019-07-12(万方平台首次上网日期,不代表论文的发表时间)
共5页
309-313